# Autologous Cord Blood Cells for Prevention of BPD in Preterm

> **NCT04311476** · PHASE2 · COMPLETED · sponsor: **yangjie** · enrollment: 62 (actual)

## Conditions studied

- Safety Issues
- BPD - Bronchopulmonary Dysplasia
- Neonatal Death

## Interventions

- **OTHER:** Autologous Umbilical Cord Blood Mononuclear Cells infusion Therapy
- **DRUG:** 0.9% Sodiun Chloride

## Key facts

- **NCT ID:** NCT04311476
- **Lead sponsor:** yangjie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311476, "Autologous Cord Blood Cells for Prevention of BPD in Preterm". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04311476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*